Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20179995

Download in:

View as

General Info

PMID
20179995